查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434627

脱髮症治疗药物市场：按脱髮症类型、性别、给药途径- 全球预测 2024-2030

Alopecia Drugs Market by Alopecia Types (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Gender (Men, Women), Route of Administration - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年脱髮症药物市场规模为12.3亿美元，预计2024年将达到13.7亿美元，2030年将达到27亿美元，复合年增长率为11.90%。

全球脱髮症治疗市场

主要市场统计
基准年[2023] 12.3亿美元
预测年份 [2024] 13.7亿美元
预测年份 [2030] 27亿美元
复合年增长率（%） 11.90%
脱髮治疗药物市场-IMG1

脱髮症是一种身体任何部位（包括头皮）脱髮的疾病，男性和女性都会受到影响。脱髮症药物可作为药物干预措施，防止进一步脱髮、促进脱髮再生或解决根本原因。例如，Finasteride主要用于治疗男性雄性脱髮症，并抑制 5-α 还原酶，将睪固酮转化为二氢睪固酮 (DHT) 的酶。另一方面，米诺地尔是一种血管扩张剂，最初是为了治疗高血压而开发的，已被证明可以促进男性和女性的头髮生长。此外，正在研究新的方法，包括针对参与免疫讯号途径的Janus激酶蛋白的 JAK 抑制剂，以及利用自体血液样本中的生长因子的富血小板血浆疗法。由于自体自体免疫疾病的迅速增加、不健康的生活习惯以及缺乏运动导致全球脱髮症，全球脱髮治疗市场正在显着增长。此外，许多非政府组织正在积极努力提高人们对脱髮症的意识提升，进一步促进市场成长。然而，对脱髮症治疗对健康的负面影响和功效的担忧正在限制市场的扩张。此外，人们对植髮和美容疗程的日益偏好也可能阻碍药物干预措施的采用。同时，监管机构对脱髮症新型系统疗法的核准不断增加，为市场进入者提供了利润丰厚的机会。此外，斑秃治疗脱髮症正在进行的研究和开发活动为未来的进步提供了广阔的前景。

区域洞察

在美洲，脱髮症和雄性脱髮症的盛行率不断上升正在推动市场的发展。除了越来越注重外表之外，多样化的人口特征也推动了对有效脱髮治疗的需求。此外，大型製药企业的存在、FDA 对新脱髮症治疗药物的核准迅速增加，以及对新治疗方法研发的持续投资正在推动该地区的市场开拓。由于各种脱髮症的盛行率不断增加以及患者对可用治疗方案的认识不断提高，亚太地区的脱髮症药物行业呈现出广阔的前景。在日本、中国、印度、韩国和澳洲等国家，由于都市区因压力而出现更多脱髮，脱髮症治疗的需求正在迅速增加。亚太地区的新兴经济体也在资助与皮肤病学和头髮科学相关的研究倡议，以满足不断增长的需求。在 EMEA（欧洲、中东和非洲）地区，随着消费者偏好随着医疗技术的进步而发展，全球脱髮症药物市场继续保持积极的发展轨迹。消费者对有效治疗方法的认识不断提高以及政府改善医疗基础设施的努力正在刺激这个多元化地区的成长机会。

FPNV定位矩阵

FPNV 定位矩阵对于评估脱髮症治疗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对脱髮症治疗药物市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-脱髮症治疗药物市场的市场规模和预测是多少？

2-在脱髮症治疗药物市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-脱髮症治疗药物市场的技术趋势和法律规范是什么？

4-脱髮症治疗药物市场主要供应商的市场占有率是多少？

5-进入脱髮症药市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球自体免疫疾病的盛行率增加
      • 不健康的生活方式和缺乏身体活动的现象正在增加
      • 提高人们对脱髮症状况认识的非政府组织数量不断增加
    • 抑制因素
      • 对脱髮症药物及其有效性的负面健康影响的担忧
    • 机会
      • 新监管机构核准脱髮症新系统治疗方法
      • 加速脱髮症治疗的研发活动
    • 任务
      • 毛髮移植和美容疗程的需求迅速增加
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章脱髮症治疗药物市场：依脱髮症类型分类

  • 脱髮症
  • 全脱髮症
  • 脱髮症

第七章脱髮症治疗药物市场：依性别

  • 男性
  • 女士

第八章脱髮症治疗药物市场：依给药途径

  • 可注射的
  • 口服
  • 局部的

第九章 北美和南美脱髮症治疗药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太脱髮症治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的脱髮症治疗药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析
    • 併购
    • 奖项/奖励/扩展

第13章竞争产品组合

  • 主要公司简介
    • AndroScience Corporation
    • Capillus, LLC by Curallux, LLC
    • Cipla Inc.
    • Concert Pharmaceuticals, Inc.
    • Daiichi Sankyo Company, Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Eli Lilly and Company
    • Hairline Co.
    • Merck & Co., Inc.
    • The Himalaya Drug Company
    • Vitabiotics Ltd.
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-436901065BAC

[187 Pages Report] The Alopecia Drugs Market size was estimated at USD 1.23 billion in 2023 and expected to reach USD 1.37 billion in 2024, at a CAGR 11.90% to reach USD 2.70 billion by 2030.

Global Alopecia Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.23 billion
Estimated Year [2024] USD 1.37 billion
Forecast Year [2030] USD 2.70 billion
CAGR (%) 11.90%
Alopecia Drugs Market - IMG1

Alopecia is a medical condition indicated by hair loss from the scalp or other body parts, affecting both males and females. Alopecia drugs serve as pharmacological interventions to prevent further hair loss, stimulate the regrowth of lost hair or address underlying causes. For instance, Finasteride is primarily utilized for treating androgenetic alopecia in men by inhibiting the enzyme 5-alpha-reductase responsible for converting testosterone into dihydrotestosterone (DHT) - a hormone linked to male pattern baldness. On the other hand, Minoxidil is a vasodilator initially developed to treat hypertension that has been approved for promoting hair growth in both sexes. Moreover, novel approaches, such as JAK inhibitors targeting Janus kinase proteins involved in immune signaling pathways or Platelet-Rich Plasma therapy harnessing growth factors from autologous blood samples, are under investigation. The global alopecia drugs market is experiencing significant growth due to the worldwide surging prevalence of autoimmune diseases, unhealthy lifestyle habits, and physical inactivity contributing to hair loss. Furthermore, numerous NGOs are actively working to raise awareness about alopecia, further fueling market growth. However, concerns about alopecia drugs' adverse health impacts and efficacy act as restraining factors for the market's expansion. Additionally, a surge in preference for hair growth transplants and cosmetic treatments may hinder the adoption of pharmaceutical interventions. On the other hand, emerging regulatory approvals for novel systemic therapies for alopecia areata offer lucrative opportunities for market players. Additionally, ongoing research and development activities in alopecia management bring promising prospects for future advancements.

Regional Insights

In the Americas, the market is primarily driven by a rising incidence of alopecia areata and male-pattern baldness. The increasing emphasis on aesthetic appearances combined with a diverse demographic profile contributes to the need for effective hair loss treatments. Moreover, the presence of leading pharmaceutical companies, surging FDA approvals for novel alopecia treatments, and continuous investments in research and development for novel therapies have bolstered market growth in this region. The APAC shows promising potential for the alopecia drug industry due to the increased prevalence of various hair loss disorders and growing patient awareness about available treatment options. Countries such as Japan, China, India, South Korea, and Australia are experiencing an upsurge in the need for alopecia drugs as their urban population experiences higher levels of stress-induced hair loss. Emerging economies in the APAC region are also funding research initiatives related to dermatology and trichology to meet growing needs. In the EMEA region, evolving consumer preferences alongside advances in medical technology continue to foster positive trajectories within the global alopecia drug market. Rising consumer awareness about effective treatments and government initiatives to improve healthcare infrastructure has stimulated growth opportunities within this diverse territory.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alopecia Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alopecia Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Drugs Market, highlighting leading vendors and their innovative profiles. These include AndroScience Corporation, Capillus, LLC by Curallux, LLC, Cipla Inc., Concert Pharmaceuticals, Inc., Daiichi Sankyo Company, Ltd., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Hairline Co., Merck & Co., Inc., The Himalaya Drug Company, and Vitabiotics Ltd..

Market Segmentation & Coverage

This research report categorizes the Alopecia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Alopecia Types
    • Alopecia Areata
    • Alopecia Totalis
    • Alopecia Universalis
  • Gender
    • Men
    • Women
  • Route of Administration
    • Injectable
    • Oral
    • Topical
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Alopecia Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alopecia Drugs Market?

3. What are the technology trends and regulatory frameworks in the Alopecia Drugs Market?

4. What is the market share of the leading vendors in the Alopecia Drugs Market?

5. Which modes and strategic moves are suitable for entering the Alopecia Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Alopecia Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of autoimmune diseases across the globe
      • 5.1.1.2. Surging adoption of unhealthy lifestyles and physical inactivity
      • 5.1.1.3. Increasing number of NGOs to create awareness about alopecia condition
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impact of alopecia drugs and concern with drugs efficacy
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging regulatory approvals for the novel systemic treatment for alopecia areata
      • 5.1.3.2. Accelerating research and developments activities for alopecia management
    • 5.1.4. Challenges
      • 5.1.4.1. Surge in preference for the hair growth transplant and cosmetic treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Alopecia Drugs Market, by Alopecia Types

  • 6.1. Introduction
  • 6.2. Alopecia Areata
  • 6.3. Alopecia Totalis
  • 6.4. Alopecia Universalis

7. Alopecia Drugs Market, by Gender

  • 7.1. Introduction
  • 7.2. Men
  • 7.3. Women

8. Alopecia Drugs Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Americas Alopecia Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Alopecia Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Alopecia Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. Sun Pharma to acquire US-based Concert Pharmaceuticals for USD 576 million
    • 12.3.2. Award, Recognition, & Expansion
      • 12.3.2.1. FDA Approves Pfizer's Alopecia Drug
      • 12.3.2.2. FDA Approves Lilly and Incyte's OLUMIANT (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. AndroScience Corporation
    • 13.1.2. Capillus, LLC by Curallux, LLC
    • 13.1.3. Cipla Inc.
    • 13.1.4. Concert Pharmaceuticals, Inc.
    • 13.1.5. Daiichi Sankyo Company, Ltd.
    • 13.1.6. Dr. Reddy's Laboratories Ltd.
    • 13.1.7. Eli Lilly and Company
    • 13.1.8. Hairline Co.
    • 13.1.9. Merck & Co., Inc.
    • 13.1.10. The Himalaya Drug Company
    • 13.1.11. Vitabiotics Ltd.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ALOPECIA DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ALOPECIA DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ALOPECIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ALOPECIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ALOPECIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ALOPECIA DRUGS MARKET DYNAMICS
  • FIGURE 7. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2023 VS 2030 (%)
  • FIGURE 8. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 10. ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ALOPECIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ALOPECIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ALOPECIA DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ALOPECIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 6. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 10. ALOPECIA DRUGS MARKET SIZE, BY MEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ALOPECIA DRUGS MARKET SIZE, BY WOMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 13. ALOPECIA DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ALOPECIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ALOPECIA DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. ALOPECIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 144. ALOPECIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. ALOPECIA DRUGS MARKET LICENSE & PRICING